News
April 3, 2025 /PRNewswire/ -- ResVita Bio, a therapeutics company focused on treatments for skin diseases, today announced that the FDA awarded the Orphan Drug Designation to RVB-003 for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback